SCHEMBL7641014

SCHEMBL7641014

CC(C)c1ccccc1-c1csc(C(N)=O)c1S(N)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.46
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
HTR2B P41595 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
BCAT2 O15382 1/20 0.33
ALOX5 P09917 1/20 0.33
FABP4 P15090 1/20 0.32
FABP5 Q01469 1/20 0.32
USP1 O94782 1/20 0.32
WDR48 Q8TAF3 1/20 0.32
NPFFR1 Q9GZQ6 1/20 0.32
NPFFR2 Q9Y5X5 1/20 0.32
FGFR1 P11362 1/20 0.32
FGFR2 P21802 1/20 0.32
FGFR4 P22455 1/20 0.32
FGFR3 P22607 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7646547 0.82 CA12 (0.42) CA12CA1CA2CA9HTR2B
SCHEMBL7640481 0.82 HTR2B (0.47) CA12CA1CA2CA9HTR2B
SCHEMBL6913314 0.80 FGFR1 (0.38) CA12CA1CA2CA9HTR2B
SCHEMBL7647137 0.79 IKBKB (0.43) CA12CA1CA2CA9LMNA
SCHEMBL7643245 0.78 CYP3A4 (0.41) CA1CA2CA9BCAT2LMNA
SCHEMBL7643298 0.73 ALDH1A1 (0.43) CA12CA1CA2LMNA
SCHEMBL29493488 0.69 BCAT2 (0.53) CA12CA1CA2CA9GABRA1
SCHEMBL6909617 0.68 CA2 (0.41) CA12CA1CA2CA9LMNA
SCHEMBL6906325 0.68 LMNA (0.44) CA2BCAT2LMNA
Acetic Acid SCHEMBL8910187 0.65 BCAT2 (0.53) CA12CA1CA2CA9BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432994-B1 CARDIOVASCULAR DISORDERS, GLAUCOMA; ANTIINFLAMMATORY, WOUND HEALING, HYPOTENSIVE, ANTIASTHMATIC, AND ANTIANAPHYLACTIC AGENTS TEXAS BIOTECHNOLOGY CORPORATION 2002-08-13 US disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed